protection

Kenya has begun a new phase in its HIV prevention strategy with the introduction of Lenacapavir, a long-acting injectable pre-exposure prophylaxis (PrEP). The initiative, confirmed on February 17, 2026, marks Kenya as the first East African nation to implement this advanced prevention option. The rollout is a collaboration between the Ministry of Health and the […]